Skip to main content
Log in

The Use and Safety of Non-Allopathic Indian Medicines

  • Review Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Non-allopathic Indian medicines, referred to elsewhere in the world as complementary and alternative medicine have gathered increasing recognition in recent years with regard to both treatment options and health hazards. Ayurveda, Siddha, Unani and homeopathy are practiced in India as non-allopathic systems. These systems comprise a wide range of therapeutic approaches that include diet, herbs, metals, minerals, precious stones and their combinations as well as nondrug therapies. Ayurveda is the oldest system of medicine in the world and by far the most commonly practiced form of non-allopathic medicine in India, particularly in rural India, where 70% of the population lives.

The difference between modern medicine and these systems stems from the fact that the knowledge base of many of the above systems, unlike Western medicine, is based on years of experience, observations, empiricism and intuition and has been handed down generations both through word of mouth and treatises. The focus on non-allopathic systems of medicine in India can be attributed to various causes including a need to revive a rich tradition, the dependency of 80% of the country’s population on these drugs, their easy availability, increasing worldwide use of these medicines, the lack of focused concerted scientific research and the abuse of these systems by quacks. Elsewhere, the increasing use of herbal products worldwide and the growth of the herbal product industry has led to increasing concern regarding their safety. The challenges in these non-allopathic systems relate to the patient, physician, regulatory authorities, the abuse/misuse of these medicines, quality and purity issues. Safety monitoring is mandated by a changing ecological environment, the use of insecticides, new manufacturing techniques, an as yet unregulated pharmaceutical industry, the availability of combinations of herbs over the counter and not mentioned in ancient Ayurvedic texts, and the need to look at the active principles of these medicines as potential chemotherapeutic agents.

The Indian traditional medicine industry has come a long way from the times when it was considered unnecessary to test these formulations prior to use, to the introduction of Good Manufacturing Practice guidelines for the industry. However, we still have a long way to go. The conflict between the traditional practitioners and the purists demanding evidence of safety and efficacy needs to be addressed. There is an urgent need for the practitioners of the allopathic and non-allopathic systems to work together to optimise the risk-benefit profile of these medicines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

References

  1. Stickel F, Seitz HK. The efficacy and safety of comfrey. Public Health Nutr 2000; 3: 501–8

    PubMed  CAS  Google Scholar 

  2. Srinivasan P. National Health policy for traditional medicine. World Health Forum 1995; 16: 190–3

    PubMed  CAS  Google Scholar 

  3. Lele RD. Ayurveda (ancient Indian system of medicine) and modern molecular medicine. J Assoc Physicians India 1999; 47: 625–8

    PubMed  CAS  Google Scholar 

  4. Singh RH. The holistic principles of Ayurvedic medicine. 1st ed. Varanasi (India): Chaukhamba Sanskrit Pratishthan, 1998

    Google Scholar 

  5. Trevelyan J. Complementary medicine: herbal medicine. Nurs Times 1993; 89: 36–8

    PubMed  CAS  Google Scholar 

  6. Mishra L, Singh BB, Dagenais S. Ayurveda: a historical perspective and principles of the traditional healthcare system in India. Altern Ther Health Med 2001; 7: 36–42

    PubMed  CAS  Google Scholar 

  7. Lenora RB. Ayurveda medicine. Clin Pediatr (Phila) 1968; 7: 239–42

    Article  CAS  Google Scholar 

  8. Bhishagaratna KK. Sushruta Samhita. Vol 1, 1st ed. Varanasi (India): Chowkhamba Sanskrit Series Office, 1998

  9. Dahanukar SA, Thatte UM, Rege NN. Pharmacology in Ayurveda: introduction. Indian Pract 1998; 5: 409–11

    Google Scholar 

  10. Subbarayappa BV. Siddha medicine: an overview. Lancet 1997; 350: 1841–4

    Article  PubMed  CAS  Google Scholar 

  11. Satyavati GV. Some traditional medical systems and practices of global importance. Indian J Med Res 1982; 76: 1–26

    PubMed  Google Scholar 

  12. Mahabir RC, Son-Hing J, Tam AL, et al. Ancient Indian civilization: ahead by a nose. J Invest Surg 2001; 14: 3–5

    Article  PubMed  CAS  Google Scholar 

  13. Zollman C, Vickers A. What is complementary medicine? BMJ 1999; 319: 693–6

    Article  PubMed  CAS  Google Scholar 

  14. Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. Geneva: World Health Organization, WHO/EDM/TRM/2001.2

  15. Nayak B. Ayurmedline. Ayurvedic drug index. Ayurmedline, Bangalore (India). Jan-Jun, 2001

    Google Scholar 

  16. Vaidya AB, Vaidya RA, Nagral SI. Ayurveda and a different kind of evidence: from Lord Macaulay to Lord Walton (1835 to 2001 AD). J Assoc Physicians India 2001; 49: 534–7

    PubMed  CAS  Google Scholar 

  17. WHO. Regulatory situation of herbal medicine: a worldwide review. Geneva: World Health Organization, WHO/TRM/98.1

  18. Astin JA. Why patients use alternative medicine. JAMA 1998; 279: 1548–53

    Article  PubMed  CAS  Google Scholar 

  19. Furnham A. Why people choose complementary medicine. In: Andritzky W, editor. Yearbook of cross cultural medicine and psychotherapy. Berlin: VWB, 1994: 165–8

    Google Scholar 

  20. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-97. JAMA 1998; 280: 1569–75

    Article  PubMed  CAS  Google Scholar 

  21. Dahanukar SA, Thatte UM, Rege NN. Pharmacology in Ayurveda: VI. Adverse reactions to Ayurvedic drugs. Indian Pract 1998; 51: 815–21

    Google Scholar 

  22. Chopra A, Doiphode V. Ayurvedic medicine. Med Clin North Am 2002; 86: 75–89

    Article  PubMed  Google Scholar 

  23. Okamato T, Hino O. Drug development with hints from traditional Indian Ayurveda medicine: hepatitis and rheumatoid arthritis as an example. Int J Mol Med 2000; 6: 613–5

    Google Scholar 

  24. Dandekar UP, Chandra RS, Dalvi SS, et al. Analysis of a clinical important interaction between phenytoin and shankhapushpi, an ayurvedic preparation. J Ethnopharmacol 1992; 35: 285–8

    Article  PubMed  CAS  Google Scholar 

  25. Kshirsagar NA, Dalvi SS, Joshi MV, et al. Phenytoin and Ayurvedic preparation-clinically important interaction in epileptic patients. J Assoc Physicians India 1992; 40: 354–5

    PubMed  CAS  Google Scholar 

  26. Garg SK, Islam AS, Kumar N, et al. Effect of Mentat on the pharmacokinetics of single and multiple doses of phenytoin in rabbits. Neurol India 1999; 47: 104–7

    PubMed  CAS  Google Scholar 

  27. Koumaravelou K, Adithan C, Shashindran CH, et al. Effect of honey on carbamazepine kinetics in rabbits. Ind J Exp Biol 2002; 40: 560–3

    CAS  Google Scholar 

  28. Greeson JM. St John’s wort (Hypericum perforatum): a review of the current pharmacological, toxicological and clinical literature. Psychopharmacology (Berl) 2001; 153: 402–14

    Article  CAS  Google Scholar 

  29. Tomassoni AJ, Simone K. Herbal medicines for children: an illusion of safety? Curr Opin Pediatr 2001; 13: 162–9

    Article  PubMed  CAS  Google Scholar 

  30. LaFrance WC, Lauterbach EC, Coffey CE. The use of herbal alternative medicine in neuropsychiatry. J Neuropsychiatry Clin Neurosci 2000; 12: 177–92

    Article  PubMed  CAS  Google Scholar 

  31. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, gingko or ginseng: nature of the evidence. Ann Pharmacother 2000; 34: 1478–82

    PubMed  CAS  Google Scholar 

  32. Ernst E, Pittler MH. The efficacy and safety of feverfew (tanacetum parthenium L): an update of a systematic review. Public Health Nutr 2000; 3: 509–14

    Article  PubMed  CAS  Google Scholar 

  33. Fugh-Berman A, Ernst E. Herb-drug interactions: review of assessment of report reliability. Br J Clin Pharmacol 2001; 52: 587–95

    Article  PubMed  CAS  Google Scholar 

  34. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs. Drugs 2001; 61(15): 2163–75

    Article  PubMed  CAS  Google Scholar 

  35. Kshirsagar NA. Misleading herbal Ayurvedic brand name. Lancet 1993; 341: 1595–6

    Article  PubMed  CAS  Google Scholar 

  36. Coppes MJ, Anderson RA, Egeler RM, et al. Alternative therapies for the treatment of childhood cancer. N Engl J Med 1998; 339: 846–7

    Article  PubMed  CAS  Google Scholar 

  37. Sharma RK, Dash B. Charaka Samhita. 6th ed. Varanasi (India). Chaukhamba Sanskrit Studies, 1999

    Google Scholar 

  38. Subramaniam A. The problems and prospects of plant drug research in India: pharmacological evaluation of ecotypes in drug development. Indian J Pharmacol 2001; 33: 145–6

    Google Scholar 

  39. Marrone CM. Safety issues with herbal products. Ann Pharmacother 1999; 33: 1359–62

    Article  PubMed  CAS  Google Scholar 

  40. Cui J, Garle M, Eneroth P, et al. What do commercial ginseng preparations contain [letter]. Lancet 1994; 344: 134

    Article  PubMed  CAS  Google Scholar 

  41. Prabhu MS, Platel K, Saraswathi G, et al. Effect of orally administered betel leaf (Piper betle Linn.) on digestive enzymes of pancreas and intestinal mucosa and on bile production in rats. Indian J Exp Biol 1995; 33: 752–6

    PubMed  CAS  Google Scholar 

  42. Slifman NR, Obermeyer WR, Aloi BK, et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 1998; 339: 806–11

    Article  PubMed  CAS  Google Scholar 

  43. Chan TY, Tomlinson B, Tse LK, et al. Aconitine poisoning due to Chinese herbal medicines: a review. Vet Hum Toxicol 1994; 36: 452–5

    PubMed  CAS  Google Scholar 

  44. Gogtay NJ, Dalvi SS, Rane CT, et al. A story of Ayurvedic tablets and misled epileptic patients [letter]. J Assoc Physicians India 1999; 47: 1116

    PubMed  CAS  Google Scholar 

  45. Gupta SK, Kaleekal T, Joshi S. Misuse of corticosteroids in some of the drugs dispensed as preparations from alternative systems of medicine in India. Pharmacoepidemiol Drug Saf 2000; 9: 599–602

    Article  PubMed  CAS  Google Scholar 

  46. Chopra A. Ayurvedic medicine and arthritis. Rheum Dis Clin North Am 2000; 26: 133–44

    Article  PubMed  CAS  Google Scholar 

  47. Joshi D. Rasamritam.1st ed. Varanasi (India): Chaukhambha Sanskrit Bhawan, 1998

    Google Scholar 

  48. Koh H, Woo S. Chinese proprietary medicine in Singapore. Drug Saf 2000; 23(5): 351–62

    Article  PubMed  CAS  Google Scholar 

  49. Srikantha Murthy KR. Bhavprakash of Bhavmishra. 1st ed. Varanasi (India). Krishnadas Academy, 1998

    Google Scholar 

  50. Rai J. The indigenous digestive treatments: useful/harmful. Indian Pract 2002; 55: 27–8

    Google Scholar 

  51. Shrikanthamurthy KR. Ashtanga samgraha of Vagbhata (English Translation) Vol. 1, 5th ed. Varanasi (India). Chaukhambha Orientalia, 2002

  52. Gogate VM. The text book of Ayurvedic pharmacology and therapeutics of medicinal plants. Mumbai (India). Bharatiya Vidya Bhawan, 2000

    Google Scholar 

  53. Sairam TV. Home remedies. Vol. IV. India: Penguin Books, 2002

  54. Sharma DC. India raises standards for traditional drugs [letter]. Lancet 2000; 356: 231

    Article  PubMed  CAS  Google Scholar 

  55. Notification of the Ministry of Health and Family Welfare (Department of Indian Systems of Medicine and Homeopathy). Jun 23, 2000

  56. Angell M, Kassirer JP. Alternative medicine: the risks of untested and unregulated remedies. New Engl J Med 1998; 339: 839–41

    Article  PubMed  CAS  Google Scholar 

  57. Margolin A. Investigating alternative medicine therapies in randomized controlled trials. JAMA 1998; 280: 1626–8

    Article  PubMed  CAS  Google Scholar 

  58. Bhatt AD. Clinical research on Ayurvedic therapeutics: myths, realities and challenges. J Assoc Physicians India 2001; 49: 558–62

    PubMed  CAS  Google Scholar 

  59. Antarkar DS, Vaidya AB, Doshi JC, et al. A double-blind clinical trial of Aarogyawardhini: an Ayurvedic drug in acute viral hepatitis. Indian J Med Res 1980; 72: 588–93

    PubMed  CAS  Google Scholar 

  60. Bichile LS, Rajadhyaksha A, Kini S, et al. A double-blind randomized controlled trial of Sallaki (600mg) vs diclofenac sodium (50mg) in patients with rheumatoid arthritis. Indian Pract 2001; 54: 625–32

    Google Scholar 

  61. Lodha R, Bagga A. Traditional Indian system of medicine. Ann Acad Med Singapore 2000; 29: 37–41

    PubMed  CAS  Google Scholar 

  62. Bajaj S, Vohora SB. Analgesic activity of gold preparations in Ayurveda and Unani. Indian J Med Res 1998; 108: 104–11

    PubMed  CAS  Google Scholar 

  63. Kar A, Choudhary BK, Bandyopadhyay NG. Preliminary studies on the inorganic constituents of some indigenous hypoglycaemic herbs on oral glucose tolerance test. J Ethnopharmacol 1999; 64: 179–84

    Article  PubMed  CAS  Google Scholar 

  64. Indian Council of Medical Research. Ethical guidelines for biomedical research on human subjects. New Delhi: Indian Council of Medical Research, 2000

  65. Uchil D, Rege NN, Dahanukar SA. Modern correlates for ayurvedic quality control tests for tamra bhasma. Indian Drugs 1996; 33: 384–9

    Google Scholar 

  66. Rao SKR. Encyclopedia of Indian medicine. Bombay (India): Popular Prakashan, 1985

    Google Scholar 

  67. Lele RD. Ayurveda and modern medicine. Bombay (India): Bharatiya Vidya Bhawan, 1986

    Google Scholar 

  68. Tripathi YB. Molecular approach to Ayurveda. Indian J Exp Biol 2000; 38: 409–14

    PubMed  CAS  Google Scholar 

  69. Bharatiya Vidya Bhavan’s SPARC. 111 selected medicinal plants of India. Bombay (India): CHEMEXCIL, 1992

  70. Satakopan S. Quality control for Ayurvedic, Siddha and Unani drugs: attitudes and approaches. Ind Drugs 2000; 37: 114–8

    Google Scholar 

  71. Hesketh T, Zhu WX. Traditional Chinese medicine: one country, two systems. BMJ 1997; 315: 115–7

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors have provided no information on sources of funding or on conflicts of interest directly relevant to the contents of this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N.J. Gogtay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gogtay, N., Bhatt, H., Dalvi, S. et al. The Use and Safety of Non-Allopathic Indian Medicines. Drug-Safety 25, 1005–1019 (2002). https://doi.org/10.2165/00002018-200225140-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200225140-00003

Keywords

Navigation